Literature DB >> 30051912

IL-1β activation in response to Staphylococcus aureus lung infection requires inflammasome-dependent and independent mechanisms.

Sílvia Pires1,2, Dane Parker1,2.   

Abstract

Maintaining balanced levels of IL-1β is extremely important to avoid host tissue damage during infection. Our goal was to understand the mechanisms behind the reduced pathology and decreased bacterial burdens in Ifnlr1-/- mice during lung infection with Staphylococcus aureus. Intranasal infection of Ifnlr1-/- mice with S. aureus led to significantly improved bacterial clearance, survival and decrease of proinflammatory cytokines in the airway including IL-1β. Ifnlr1-/- mice treated with recombinant IL-1β displayed increased bacterial burdens in the airway and lung. IL-1β levels in neutrophils from Ifnlr1-/- infected mice lungs were decreased when compared to neutrophils from WT mice. Mice lacking NLRP3 and caspase-1 had reduced IL-1β levels 4 h after infection, due to reductions or absence of active caspase-1 respectively, but levels at 24 h were comparable to WT infected mice. Ifnlr1-/- infected mice had decreases in both active caspase-1 and neutrophil elastase indicating an important role for the neutrophil serine protease in IL-1β processing. By inhibiting neutrophil elastase, we were able to decrease IL-1β levels by 39% in Nlrp3-/- infected mice when compared to WT mice. These results highlight the crucial role of both proteases in IL-1β processing, via inflammasome-dependent and -independent mechanisms.
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  IL-1β activation; Inflammasome; Lung infection; Staphylococcus aureus; Type III interferon

Mesh:

Substances:

Year:  2018        PMID: 30051912      PMCID: PMC6394835          DOI: 10.1002/eji.201847556

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  40 in total

1.  Staphylococcus aureus α-hemolysin mediates virulence in a murine model of severe pneumonia through activation of the NLRP3 inflammasome.

Authors:  Chahnaz Kebaier; Robin R Chamberland; Irving C Allen; Xi Gao; Peter M Broglie; Joshua D Hall; Corey Jania; Claire M Doerschuk; Stephen L Tilley; Joseph A Duncan
Journal:  J Infect Dis       Date:  2012-01-25       Impact factor: 5.226

Review 2.  Proteolytic Processing of Interleukin-1 Family Cytokines: Variations on a Common Theme.

Authors:  Inna S Afonina; Christina Müller; Seamus J Martin; Rudi Beyaert
Journal:  Immunity       Date:  2015-06-16       Impact factor: 31.745

3.  IL-1β production is dependent on the activation of purinergic receptors and NLRP3 pathway in human macrophages.

Authors:  Thomas Gicquel; Sacha Robert; Pascal Loyer; Tatiana Victoni; Aude Bodin; Catherine Ribault; Florence Gleonnec; Isabelle Couillin; Elisabeth Boichot; Vincent Lagente
Journal:  FASEB J       Date:  2015-06-26       Impact factor: 5.191

4.  Interferon-λ Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness.

Authors:  Ioanna E Galani; Vasiliki Triantafyllia; Evridiki-Evangelia Eleminiadou; Ourania Koltsida; Athanasios Stavropoulos; Maria Manioudaki; Dimitris Thanos; Sean E Doyle; Sergei V Kotenko; Kalliopi Thanopoulou; Evangelos Andreakos
Journal:  Immunity       Date:  2017-05-16       Impact factor: 31.745

5.  Inflammatory arthritis in caspase 1 gene-deficient mice: contribution of proteinase 3 to caspase 1-independent production of bioactive interleukin-1beta.

Authors:  Leo A B Joosten; Mihai G Netea; Giamila Fantuzzi; Marije I Koenders; Monique M A Helsen; Helmut Sparrer; Christine T Pham; Jos W M van der Meer; Charles A Dinarello; Wim B van den Berg
Journal:  Arthritis Rheum       Date:  2009-12

6.  Influenza A exacerbates Staphylococcus aureus pneumonia by attenuating IL-1β production in mice.

Authors:  Keven M Robinson; Sun Mi Choi; Kevin J McHugh; Sivanarayana Mandalapu; Richard I Enelow; Jay K Kolls; John F Alcorn
Journal:  J Immunol       Date:  2013-10-02       Impact factor: 5.422

7.  Staphylococcus aureus Leukocidin A/B (LukAB) Kills Human Monocytes via Host NLRP3 and ASC when Extracellular, but Not Intracellular.

Authors:  Jason H Melehani; David B A James; Ashley L DuMont; Victor J Torres; Joseph A Duncan
Journal:  PLoS Pathog       Date:  2015-06-12       Impact factor: 6.823

8.  Type I and type III interferons drive redundant amplification loops to induce a transcriptional signature in influenza-infected airway epithelia.

Authors:  Stefania Crotta; Sophia Davidson; Tanel Mahlakoiv; Christophe J Desmet; Matthew R Buckwalter; Matthew L Albert; Peter Staeheli; Andreas Wack
Journal:  PLoS Pathog       Date:  2013-11-21       Impact factor: 6.823

9.  Lambda Interferon Restructures the Nasal Microbiome and Increases Susceptibility to Staphylococcus aureus Superinfection.

Authors:  Paul J Planet; Dane Parker; Taylor S Cohen; Hannah Smith; Justinne D Leon; Chanelle Ryan; Tobin J Hammer; Noah Fierer; Emily I Chen; Alice S Prince
Journal:  mBio       Date:  2016-02-09       Impact factor: 7.867

10.  Induction of type I interferon signaling determines the relative pathogenicity of Staphylococcus aureus strains.

Authors:  Dane Parker; Paul J Planet; Grace Soong; Apurva Narechania; Alice Prince
Journal:  PLoS Pathog       Date:  2014-02-20       Impact factor: 6.823

View more
  17 in total

1.  Interleukin (IL)-1β and IL-10 Host Responses in Patients With Staphylococcus aureus Bacteremia Determined by Antimicrobial Therapy.

Authors:  Cecilia F Volk; Sarah Burgdorf; Graham Edwardson; Victor Nizet; George Sakoulas; Warren E Rose
Journal:  Clin Infect Dis       Date:  2020-06-10       Impact factor: 9.079

2.  The ClpXP Protease Contributes to Staphylococcus aureus Pneumonia.

Authors:  Gyu-Lee Kim; Lavoisier Akoolo; Dane Parker
Journal:  J Infect Dis       Date:  2020-09-14       Impact factor: 5.226

Review 3.  Type III IFNs: Beyond antiviral protection.

Authors:  Sergei V Kotenko; Amariliz Rivera; Dane Parker; Joan E Durbin
Journal:  Semin Immunol       Date:  2019-06       Impact factor: 11.130

4.  Salvia miltiorrhiza polysaccharides ameliorates Staphylococcus aureus-induced mastitis in rats by inhibiting activation of the NF-κB and MAPK signaling pathways.

Authors:  Di Zhang; Guozhong Jin; Wei Liu; Mengmeng Dou; Xiao Wang; Wanyu Shi; Yongzhan Bao
Journal:  BMC Vet Res       Date:  2022-05-27       Impact factor: 2.792

5.  Biological sex influences susceptibility to Acinetobacter baumannii pneumonia in mice.

Authors:  Sílvia Pires; Adeline Peignier; Jeremy Seto; Davida S Smyth; Dane Parker
Journal:  JCI Insight       Date:  2020-03-19

6.  Differential Induction of Type I and III Interferons by Staphylococcus aureus.

Authors:  Adeline Peignier; Paul J Planet; Dane Parker
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

Review 7.  Interferon-λ orchestrates innate and adaptive mucosal immune responses.

Authors:  Liang Ye; Daniel Schnepf; Peter Staeheli
Journal:  Nat Rev Immunol       Date:  2019-06-14       Impact factor: 53.106

8.  Adherent-invasive E. coli metabolism of propanediol in Crohn's disease regulates phagocytes to drive intestinal inflammation.

Authors:  Monica Viladomiu; Maeva L Metz; Svetlana F Lima; Wen-Bing Jin; Lance Chou; Chun-Jun Guo; Gretchen E Diehl; Kenneth W Simpson; Ellen J Scherl; Randy S Longman
Journal:  Cell Host Microbe       Date:  2021-02-03       Impact factor: 21.023

9.  IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus.

Authors:  Rosanne Spolski; Erin E West; Peng Li; Sharon Veenbergen; Sunny Yung; Majid Kazemian; Jangsuk Oh; Zu-Xi Yu; Alexandra F Freeman; Stephen M Holland; Philip M Murphy; Warren J Leonard
Journal:  Elife       Date:  2019-04-16       Impact factor: 8.140

10.  Growth and Stress Tolerance Comprise Independent Metabolic Strategies Critical for Staphylococcus aureus Infection.

Authors:  Gyu-Lee Kim; Thomas A Hooven; Javiera Norambuena; Barry Li; Jeffrey M Boyd; Jason H Yang; Dane Parker
Journal:  mBio       Date:  2021-06-08       Impact factor: 7.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.